1 Min Read
April 20 (Reuters) - NanoCarrier Co Ltd :
* Says it decides to resume phase III clinical trial of NC-6004
Source text in Japanese: goo.gl/rqOxuM
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.